{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04615",
    "Peptide Name": "AR-1-S (Arenicin-1 analog C to S, Arg-rich, synthetic AMPs, UCLL1)",
    "Source": "amino acid substitution, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RWSVYAYVRVRGVLVRYRRSW",
    "Sequence Length": 21,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "NonHelixBeta",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 3.05,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "43%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (90.48%) toArenicin-1R: 29%, V: 24%, S=W: 10%.Activity: active against E. coli KCTC 1682 (MIC 16 uM), P. aeruginosa KCTC 1637 (MIC 8 uM), S.aureus KCTC 1621 (MIC 4 uM), and S. epidermidis KCTC 1917 (MIC 8 uM).SAR: C to S changes led to antibacterial activity decrease by 2-4 fold (4 fold P. aeruginosa).",
    "Author": "Lee JU, Kang DI, Zhu WL, Shin SY, Hahm KS, Kim Y.2007",
    "Reference": "Biopolymers. 2007;88(2):208-16. doi: 10.1002/bip.20700.PubMed",
    "Title": "Solution structures and biological functions of the antimicrobial peptide, arenicin-1, and its linear derivative."
  },
  "3D Structure": []
}